4th Quarter - Report

BRYAN CAVE LEIGHTON PAISNER LLP for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform Act of 2009- HR 1260, S 515, S610; Pathway for Biosimilars Act- HR 1548; Promoting Innovation and Access to Life-Saving medicine Act - HR 1427; The Affordable Health Care for America Act. HR 3962- general intelligence and contact regarding comparative effectiveness research; America's Healthy Future Act of 2009. S. 1796-general intelligence and contact regarding importation

LobbyistCovered position, as disclosed
CYNTHIA E BERRY —
JULIUS W HOBSON New Legislative Assistant, Sen Charles Robb
MATT JESSEE —
BRODERICK JOHNSON —
DAVID RUSSELL —
HARRY ANASTASIOS SPORIDIS —
JENNIFER STEWART —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), H.R. 3962 (111th), S. 1796 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.